These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

287 related items for PubMed ID: 1379696

  • 1. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides.
    Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, Resh MD, Rios CB, Silverman L, Kuriyan J.
    Nature; 1992 Aug 20; 358(6388):646-53. PubMed ID: 1379696
    [Abstract] [Full Text] [Related]

  • 2. Crystal structure of the phosphotyrosine recognition domain SH2 of the Src oncogene product complexed with tyrosine-phosphorylated peptides.
    Waksman G.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 20; 40(5):611-8. PubMed ID: 7526915
    [Abstract] [Full Text] [Related]

  • 3. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ, Shoelson SE, Harrison SC.
    Nature; 1993 Mar 04; 362(6415):87-91. PubMed ID: 7680435
    [Abstract] [Full Text] [Related]

  • 4. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site.
    Mikol V, Baumann G, Keller TH, Manning U, Zurini MG.
    J Mol Biol; 1995 Feb 17; 246(2):344-55. PubMed ID: 7532720
    [Abstract] [Full Text] [Related]

  • 5. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
    Karlsson T, Songyang Z, Landgren E, Lavergne C, Di Fiore PP, Anafi M, Pawson T, Cantley LC, Claesson-Welsh L, Welsh M.
    Oncogene; 1995 Apr 20; 10(8):1475-83. PubMed ID: 7537362
    [Abstract] [Full Text] [Related]

  • 6. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia.
    Vihinen M, Nilsson L, Smith CI.
    Biochem Biophys Res Commun; 1994 Dec 15; 205(2):1270-7. PubMed ID: 7528500
    [Abstract] [Full Text] [Related]

  • 7. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate.
    Hoedemaeker FJ, Siegal G, Roe SM, Driscoll PC, Abrahams JP.
    J Mol Biol; 1999 Oct 01; 292(4):763-70. PubMed ID: 10525402
    [Abstract] [Full Text] [Related]

  • 8. Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase.
    Lee CH, Kominos D, Jacques S, Margolis B, Schlessinger J, Shoelson SE, Kuriyan J.
    Structure; 1994 May 15; 2(5):423-38. PubMed ID: 7521735
    [Abstract] [Full Text] [Related]

  • 9. Signal transduction. Fishing in Src-infested waters.
    Petsko GA.
    Nature; 1992 Aug 20; 358(6388):625-6. PubMed ID: 1379695
    [No Abstract] [Full Text] [Related]

  • 10. The three-dimensional solution structure of the SH2 domain from p55blk kinase.
    Metzler WJ, Leiting B, Pryor K, Mueller L, Farmer BT.
    Biochemistry; 1996 May 21; 35(20):6201-11. PubMed ID: 8639560
    [Abstract] [Full Text] [Related]

  • 11. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M, Martin GS.
    Oncogene; 1996 Feb 15; 12(4):727-34. PubMed ID: 8632894
    [Abstract] [Full Text] [Related]

  • 12. Structure of the regulatory domains of the Src-family tyrosine kinase Lck.
    Eck MJ, Atwell SK, Shoelson SE, Harrison SC.
    Nature; 1994 Apr 21; 368(6473):764-9. PubMed ID: 7512222
    [Abstract] [Full Text] [Related]

  • 13. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.
    Xu RX, Word JM, Davis DG, Rink MJ, Willard DH, Gampe RT.
    Biochemistry; 1995 Feb 21; 34(7):2107-21. PubMed ID: 7532003
    [Abstract] [Full Text] [Related]

  • 14. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution.
    Tong L, Warren TC, King J, Betageri R, Rose J, Jakes S.
    J Mol Biol; 1996 Mar 01; 256(3):601-10. PubMed ID: 8604142
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the cellular src protein tyrosine kinase: interactions of the carboxyl terminal sequences residing between the kinase domain and tyrosine-527.
    Cobb BS, Parsons JT.
    Oncogene; 1993 Nov 01; 8(11):2897-903. PubMed ID: 7692368
    [Abstract] [Full Text] [Related]

  • 16. P56lck: a transducing protein that binds to SH2 containing proteins and to phosphotyrosine containing proteins.
    Ramos-Morales F, Douté M, Fischer S.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 01; 40(5):695-700. PubMed ID: 7526919
    [Abstract] [Full Text] [Related]

  • 17. Mutational investigation of the specificity determining region of the Src SH2 domain.
    Bradshaw JM, Mitaxov V, Waksman G.
    J Mol Biol; 2000 Jun 02; 299(2):521-35. PubMed ID: 10860756
    [Abstract] [Full Text] [Related]

  • 18. v-Src induces Shc binding to tyrosine 63 in the cytoplasmic domain of the LDL receptor-related protein 1.
    Barnes H, Ackermann EJ, van der Geer P.
    Oncogene; 2003 Jun 05; 22(23):3589-97. PubMed ID: 12789267
    [Abstract] [Full Text] [Related]

  • 19. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
    Peri KG, Gervais FG, Weil R, Davidson D, Gish GD, Veillette A.
    Oncogene; 1993 Oct 05; 8(10):2765-72. PubMed ID: 7690927
    [Abstract] [Full Text] [Related]

  • 20. Probing the "two-pronged plug two-holed socket" model for the mechanism of binding of the Src SH2 domain to phosphotyrosyl peptides: a thermodynamic study.
    Bradshaw JM, Grucza RA, Ladbury JE, Waksman G.
    Biochemistry; 1998 Jun 23; 37(25):9083-90. PubMed ID: 9636054
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.